RvD1 is a ligand for ALXR/FPR2, and its effects have been shown in an endotoxin-induced uveitis rat model where direct IVT administration of RvD1 improved clinical scores and reduced TNF-α and NF-κB activation [29]. Here, FPR2 is linked to uveitis.